Event
Clinical Trials Design: Bayesian Approaches and Simulations Postponed to April 14, 2015
Tuesday, January 13, 2015
2:00 p.m.-3:00 p.m.
FDA-White Oak Bldg.
Ann Anonsen
aanonsen@umd.edu
Speaker:
Donald Berry, Ph.D. Professor, Department of Biostatistics
The University of Texas, MD Anderson Cancer Center, Houston, Texas
BIO:
Donald Berry is a professor in the Department of Biostatistics of the University of Texas M.D. Anderson Cancer Center. He was founding Chair of this department in 1999 and founding Head of the Division of Quantitative Sciences, including the Department of Bioinformatics and Computational Biology, in 2006. Dr. Berry received a Ph.D. in statistics from Yale University, and previously served on the faculties of the University of Minnesota and Duke University. He held endowed faculty positions at Duke University and at M.D. Anderson. Since 1990 he has served as a faculty statistician on the Breast Cancer Committee of the Cancer and Leukemia Group B, a national oncology group, now part of The Alliance. He has designed and supervised the conduct of many large U.S. intergroup trials in breast cancer.
A principal focus of his research is the use of biomarkers in cancer and other diseases for learning which patients benefit from which therapies, based on genomics and phenotype. He designed and is a co-PI of I-SPY 2 www.ispy2.org, a Bayesian adaptive platform clinical trial in high-risk early breast cancer whose goal is matching experimental therapies with patient subsets defined by tumor molecular characteristics.
Since 1997 he has served on the PDQ Screening and Prevention Board of the National Cancer Institute for which he received the National Institutes of Health Award of Merit in 2010. Through Berry Consultants, LLC he has designed many innovative clinical trials in all therapeutic areas for pharmaceutical and medical device companies and for NIH cooperative groups.
Dr. Berry is the author of several books on statistical methodology and over 300 published articles, including first-authored articles in the major medical journals. Dr. Berry has been the principal investigator for numerous research grants from the National Institutes of Health and the National Science Foundation. He is a Fellow of the American Statistical Association and the Institute of Mathematical Statistics.
